Showing results (5091-5100 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|August 30, 2023
A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancersDavid Starks, Luis Rojas-Espaillat, Tobias Meissner, et al.Cancer Medicine|August 30, 2023
Revealing metastatic castration-resistant prostate cancer master regulator through lncRNAs-centered regulatory networkRafaella Sousa Ferraz, João Vitor Ferreira Cavalcante, Leandro Magalhães, et al.Cancer Medicine|August 28, 2023
Predicting cervical lymph node metastasis in OSCC based on computed tomography imaging genomicsNenghao Jin, Bo Qiao, Min Zhao, et al.Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.Cancer Medicine|September 5, 2023
Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumorsWenlin Chen, Siying Guo, Yaning Wang, et al.Cancer Medicine|September 1, 2023
The expression of nicotinic acetylcholine receptor subunits and their associations with local immune cells and prognosis in oral squamous cell carcinomaChi-Maw Lin, Long-Wei Lin, Tseng-Cheng Chen, et al.Cancer Medicine|September 11, 2023
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancerTakehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, et al.Cancer Medicine|September 9, 2023
The metastasis patterns and their prognostic features in patients with de novo metastatic breast cancer of different agesShujuan Sun, Xiaochu Man, Dongdong Zhou, et al.Cancer Medicine|September 7, 2023
Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinomaYue Ge, Sheng Ma, Junbiao Zhang, et al.Cancer Medicine|August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit studySatoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.Pageof 935